MercyOne Waterloo Cancer Center — Waterloo, Iowa

MercyOne Waterloo Cancer Center is a clinical research site located in Waterloo, Iowa, United States 50702.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

MercyOne Waterloo Cancer Center has participated in 22 clinical trials with 17 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Helsinn Healthcare SA.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MercyOne Waterloo Cancer Center?

MercyOne Waterloo Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MercyOne Waterloo Cancer Center conducted?

MercyOne Waterloo Cancer Center has 22 clinical trials on record, with 17 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma.

Is MercyOne Waterloo Cancer Center accredited by Crixeo Health?

MercyOne Waterloo Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MercyOne Waterloo Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.